Sarine recorded a $2.8m loss for 2023 as it battled macro-economic challenges in China and beyond, as well as increasing disruption from lab growns.
The Israel-based diamond tech business made an $8.8m profit the previous year. Revenue for 2023 was down 27 per cent to $42.9m.
Sarine said sales of equipment and the recurring scanning revenues that came from them had been hit by lower consumer demand and manufacturers’ reduced polishing activities.
Sales to India, its biggest single market by far, fell 27 per cent to $22m.
However it did sound a note of optimism after a “challenging year”, suggesting that a sharp fall in lab grown retail prices could lower retailers’ margins and make them less attractive.
“While it may be too early to call this a new trend, the slowdown could indicate that the natural diamond and LGD segments of the diamond jewellery market are reaching a new equilibrium,” the company said.
Sarine said it had launched its Most Valuable Plan (MVP) for the optimal planning of small rough diamonds and had adapted rough planning technologies to lab growns to attract new customers and generate additional recurring revenues.
Source: IDEX